Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06607133

Thermal Ablation Vs Thyroidectomy for Large Benign Thyroid Nodules

To compare the safety, efficacy and quality of life between staged thermal ablation and thyroidectomy in the treatment of Large benign thyroid nodules.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

China-Japan Friendship Hospital

Beijing, Beijing Municipality, 100029, China

About this study

Large benign thyroid nodules (BTNs)usually cause compressive symptoms or cosmetic concerns and therefore require treatment. Thyroidectomy remains the mainstay treatment for large, symptomatic BTNs. However, if surgery is not feasible or refused, ablative approach could be considered in selected patients. However, it has been proved that single application of thermal ablation is less effective in causing shrinkage in large thyroid nodules. The possible reason is that it is difficult for single application of thermal ablation to cover all of the nodule tissue in a three-dimension if the nodule is large. In addition, nodule locations adjacent to vital structures might hinder complete treatment in one session because of safety concerns. Few studies reveal that staged thermal ablation (Pre-designed multiple sessions of thermal ablation) can also achieve complete ablation and adequate volume reduction of large benign thyroid nodules. However, there is a lack of comparison between these two methods. Thus, this study is aimed to compare the safety, efficacy, quality of life between staged thermal ablation and thyroidectomy for treating large benign thyroid nodules.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • benign thyroid nodules confirmed by surgical pathology in surgery group, and by two separate US-guided fine-needle aspiration (FNA) or core needle biopsy (CNB) in thermal ablation group;
  • the largest diameter of the nodule ≥4 cm;
  • the presence of nodule-related symptoms, cosmetic concerns, or psychological stress;
  • patients treated with surgery, or staged thermal ablation (who explicitly refused surgery);
  • more than 12-month follow-up duration

Exclusion criteria

  • suspicion of malignant nodule on ultrasound findings (e.g., marked hypoechoic, microcalcifications, or ill-defined margins);
  • comorbidities of other severe diseases;
  • without complete treatment and/or follow-up information

Treatment and study plan

Surgery

Procedure

patients undergo conventional/open thyroidectomy or endoscopic thyroidectomy for large benign thyroid nodules

staged thermal ablation

Procedure

patients undergo multiple sessions of thermal ablation for large benign thyroid nodules

Primary outcomes

  1. volume reduction ratio

    Time frame: From enrollment to the end of treatment at 12 months

    The volume reduction ratio(VRR) = [(preoperative volume - volume at the follow-up point)/preoperative volume] × 100%. The volumes of the nodules were calculated using the following equation: V=π/6 a×b×c (where V is the volume, a is the maximum diameter, b and c are the other two perpendicular diameters).

  2. Complications

    Time frame: From enrollment to the end of treatment at 12 months

    Complications related to thermal ablation or thyroidectomy during treatment procedures, at the hospital stay and follow-ups.

Secondary outcomes

  1. European Organization for Research and Treatment of Cancer Quality of Life Questionnaire

    Time frame: From enrollment to the end of treatment at 12 months

    Questionnaires of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) was used to evaluate the quality of life for cancer patients. All scales and single-item measures range from score 0-100 after linear transformation. The summary score of QLQ-C30 is used to measure the overall health-related quality-of-life (HRQoL), with a lower score indicating poorer HRQoL. And a higher score on the functional scales and global status scale indicates a better level of functioning and HRQoL, while a higher score on the symptom scales and single item means more discomfort and complaints.

  2. Thyroid Cancer-Specific Quality of Life questionnaire

    Time frame: From enrollment to the end of treatment at 12 months

    The Thyroid Cancer-Specific Quality of Life questionnaire (THYCA-QoL) was used to assess thyroid-specific symptoms in thyroid cancer survivors. The questionnaire consists of seven symptom scales (including neuromuscular, voice, concentration, sympathetic, throat/mouth, psychological and sensory problems) and six single items (including problems with scar, feeling chilly, tingling hands/feet, gained weight, headache, less interest in sex). A higher score on this scale implies more symptoms and complaints.

Study contacts

Contact information is provided by the study sponsor or research team.

Ming-an Yu, MD

CONTACT

[email protected]

86-84205756

Sponsors and collaborators

Lead sponsor

Ming-an Yu

Other

Registry information

Official study title

Comparison of Staged Thermal Ablation and Thyroidectomy for Large Benign Thyroid Nodules

Important dates

Study start
2024
Primary completion
2027
Study completion
2027
First posted
Sep 23, 2024
Registry last updated
Sep 23, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.